Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 VaccineGlobeNewsWire • 02/18/21
Novavax Announces Expanded Collaboration and License Agreement with SK Bioscience for 40 Million Doses of COVID-19 Vaccine for South KoreaGlobeNewsWire • 02/16/21
Could the U.S. Buying More COVID Vaccines Hurt Johnson & Johnson and Novavax?The Motley Fool • 02/12/21
Could Novavax Win U.S. Authorization for Its COVID Vaccine Sooner Than Expected?The Motley Fool • 02/10/21
J&J, Novavax Ask FDA To Authorize Covid Vaccines — Shares Surge HigherInvestors Business Daily • 02/05/21
Novavax's COVID Vaccine May Get U.S. Approval Sooner Than You Think: Here Is WhySeeking Alpha • 02/05/21
Here's Why These 2 Vaccine Makers Are Most Likely to Beat New COVID StrainsThe Motley Fool • 02/04/21